^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Uveal Melanoma
    Drug:Yervoy (ipilimumab) (CTLA4 inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Uveal melanoma: Other recommended regimens…Immunotherapy…ipilimumab